Transmedics Group, Inc. (TMDX) — 10-Q Filings

10-Q Filings (6)

• TransMedics Soars: Revenue Jumps 39% on Strong OCS Adoption — Oct 29, 2025 Risk: medium
  TransMedics Group, Inc. (TMDX) reported robust financial performance for the nine months ended September 30, 2025, with total revenue surging to $444.73 million
• TransMedics Soars: 39% Revenue Jump, $15.3M Net Income — Jul 30, 2025 Risk: medium
  TransMedics Group, Inc. reported a significant increase in revenue for the three months ended June 30, 2025, reaching $90.5 million, up from $65.2 million in th
• TransMedics Group Q1 2025 Update: OCS Transplant Revenue Detailed — May 8, 2025 Risk: medium
  TransMedics Group, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates, including revenue
• TransMedics Group Files Q3 2024 10-Q — Oct 29, 2024 Risk: medium
  TransMedics Group, Inc. filed its quarterly report for the period ending September 30, 2024. The company's fiscal year ends on December 31st. Key financial data
• TransMedics Group Files Q2 2024 10-Q — Aug 1, 2024 Risk: medium
  TransMedics Group, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported on its financial performance, including revenue from its OCS Tr
• TransMedics Group, Inc. Files 10-Q for Period Ending March 31, 2024 — May 2, 2024 Risk: medium
  TransMedics Group, Inc. (TMDX) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. TransMedics Group, Inc. filed a 10-Q report for the period ending Ma

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX